While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems

Biology of Reproduction

Volumn 81, Issue 1, 2009, Pages 33-39

  Robinson, John M ^a   Ackerman IV, William E ^a   Behrendt, Nicholas J ^a   Vandre, Dale D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Dysferlin; Myoferlin; Placenta; Syncytiotrophoblast; Trophoblast

Indexed keywords

DYSFERLIN; MEMBRANE PROTEIN; MYOFERLIN; UNCLASSIFIED DRUG;

ARTICLE; CELL FUSION; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MONONUCLEAR CELL; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SYNCYTIOTROPHOBLAST;

CELL FUSION; CELLS, CULTURED; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION; HL-60 CELLS; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUSCLE PROTEINS; PLACENTA; PREGNANCY; TISSUE DISTRIBUTION; TROPHOBLASTS;

EID: 67649665580     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.074591     Document Type: Article

References (36)

1. Benirschke K, Kaufmann P. Pathology of the Human Placenta, 4th ed. New York: Springer-Verlag; 2000.
2. Huppertz B, Frank FG, Kingdom JC, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998; 110:495-508. (Pubitemid 28480282)
3. Huppertz B, Tews DS, Kaufmann P. Apotosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol 2001; 205:215-253. (Pubitemid 32390831)
4. Jones CJ, Fox H. Syncytial knots and intervillous bridges in the human placenta: an ultrastructural study. J Anat 1977; 124:275-286. (Pubitemid 8218046)
5. Martin BJ, Spicer SS. Ultrastructural features of cellular maturation and aging in human trophoblast. J Ultrastruct Res 1973; 43:133-149.
6. Abumaree MH, Stone PR, Chamley LW. An in vitro model of human prophoblast deportation/shedding. Mol Hum Reprod 2006; 12:687-694. (Pubitemid 44605601)
7. Vandré DD, Ackerman WE Jr, Kniss DA, Tewari AK, Mori M, Takizawa T, Robinson JM. Dysferlin is expressed in human placenta but does not associate with caveolin. Biol Reprod 2007; 77:533-542. (Pubitemid 47328617)
8. Lyden TW, Anderson CL, Robinson JM. The endothelium but not the syncytiotrophoblast of human placenta expresses caveolae. Placenta 2002; 23:640-652. (Pubitemid 37184673)
9. Takizawa T, Anderson CL, Robinson JM. A novel Fc gamma R-defined, IgG-containing organelle in placental endothelium. J Immunol 2005; 175:2331-2339. (Pubitemid 41113842)
10. Robinson JM, Vandré DD. Antigen retrieval in cells and tissues: enhancement with sodium dodecyl sulfate. Histochem Cell Biol 2001;116:119-130. (Pubitemid 32778642)
11. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP. Defective-membrane repair in dysferlin muscular dystrophy. Nature 2003; 423:168-172. (Pubitemid 36569539)
12. Lin L, Xu B, Rote NS. Expression of endogenous retrovirus ERV-3 induces differentiation in BeWo, a choriocarcinoma model of human placental trophoblast. Placenta 1999; 20:109-118. (Pubitemid 29039258)
13. Robinson JM, Ackerman WE, Tewari AK, Kniss DA, Vandre DD. Isolation of highly enriched apical plasma membranes of the placental syncytiotrophoblast. Anal Biochem 2009; 387:87-89.
14. Kudo Y, Boyd CAR, Kimura H, Cook PR, Redman CWG, Sargent IL. Quantifying the syncytialization of human placental trophoblast BeWo cells grown in vitro. Biochim Biophys Acta 2003; 1640:25-31. (Pubitemid 36369634)
15. Rote NS. Intercellular fusion of BeWo. Placenta 2005; 26:686.
16. Kudo Y, Boyd CAR. Changes in expression and function of syncytin and its receptor, amino acid transport system B8 (ASCT2), in human placental choriocarcinoma BeWo cells during syncytialization. Placenta 2002; 23:536-541. (Pubitemid 41110473)
17. Borges M, Bose P, Frank HG, Kaufmann P, Pötgens AJ. A two-color fluorescence assayfor the measurement of syncytial fusion between trophoblast-derived cell lines. Placenta 2003; 24:959-964. (Pubitemid 37321811)
18. Al-Najiry J, Spitz B, Hanssens M, Luyten C, Pijnenborg R. Differential effects of inducers of syncytialization and apotosis on BeWo and JEG-3 choriocarcinoma cells. Hum Reprod 2006; 21:193-201. (Pubitemid 41794311)
19. Vargas A, Morean J, Le Bellego F, Lafond J, Barbean B. Induction of trophoblast cell fusion by a protein tyrosine phosphatase. Placenta 2008; 29:170-174.
20. Achanzar WE, Ward S. A nematode gene required for sperm vesicle fusion. J Cell Sci 1997; 110:1073-1081. (Pubitemid 27232277)
21. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z, Sadeh M, Mahjneh I, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998; 20:37-42. (Pubitemid 28410340)
22. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20:31-36. (Pubitemid 28410339)
23. Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, Campbell KP. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 2007; 117:1805-1813. (Pubitemid 47036314)
24. Wenzel K, Geier C, Qadri F, Hubner N, Schulz H, Erdmann B, Gross V, Bauer D, Dechend R, Dietz R, Osterziel KJ, Spuler S, et al. Dysfunction of dysferlin-deficient hearts. J Mol Med 2007; 85:1203-1214. (Pubitemid 47622228)
25. Human Protein Atlas. (URL: http://www.proteinatlas.org/index.php). (November 5, 2008).
26. Davis DB, Delmonte AJ, Ly CT, McNally EM. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum Mol Genet 2002; 9:217-226.
27. Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, Hadhazy M, McNally EM. Normal myoblast fusion requires myoferlin. Development 2005; 132:5565-5575. (Pubitemid 43125882)
28. Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P, Sessa WC. Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J Biol Chem 2007; 282:30745-30753. (Pubitemid 350035229)
29. Davis DB, Doherty KR, Delmonte AJ, McNally EM. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J Biol Chem 2002; 277:22883-22888. (Pubitemid 34967270)
30. de Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas-Garcia R, Garcia-Verdugo JM, Illa I. Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro." J Biol Chem 2006; 281:17092-17098.
31. Hochberg A, Rachmilewitz J, Eldar-Geva T, Salant T, Schneider T, de Groot N. Differentiation of choriocarcinoma cell line (JAR). Cancer Res 1992; 52:3713-3717.
32. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003; 278:50466-50473. (Pubitemid 37548892)
33. Newton AC. Protein kinase C. Seeing two domains. Curr Biol 1995; 5:973-976.
34. Nalefeski EA, Falke JJ. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci 1996; 5:2375-2390. (Pubitemid 26424851)
35. Glover L, Brown RH Jr. Dysferlin in membrane trafficking and patch repair. Traffic 2007; 8:785-794. (Pubitemid 46971627)
36. Han R, Campbell KP. Dysferlin and muscle membrane repair. Curr Opin Cell Biol 2007; 19:409-416. (Pubitemid 47277508)